Common Sensing, an evidence-based, data-driven injectable-medicine startup has raised $6.6 million in Series A funding led by Waterline Ventures. New World Health and Royal Philips with participation from Haselmeier. The Cambridge, MA-based digital health startup plans to use the funds to accelerate Common Sensing's manufacturing and commercial operations for its smart insulin pen cap solution, Gocap. The IP-protected dose monitoring solution enables patients and providers to better utilize
Read More
Common Sensing
Common Sensing, Welkin Health Partner to Develop Innovative Insulin Adherence Program
Insulin adherence remains a significant challenge with approximately 62 percent of patients discontinuing insulin in the first three months and 82 percent in the first year. To resolve this challenge, Common Sensing and Welkin Health have partnered to develop an innovative new program aimed at improving insulin adherence for people living with diabetes. A first-of-its-kind initiative, the program will combine insulin dosing data, wirelessly transmitted from Common Sensing’s Gocap™, real-time
Read More
